Inductive Bio has secured up to $21m in funding from ARPA-H to lead the development of AI drug-toxicity prediction models.

Experts said that US public health is now at risk after the CDC vaccine panel voted against the widespread recommendation for the hepatitis B vaccine at birth.

Viatris has signed definitive agreements for the sale of its equity stake in Biocon Biologics to Biocon for $815m.